Atrasentan Back on the SONAR for Diabetes and Kidney Disease Atrasentan Back on the SONAR for Diabetes and Kidney Disease

A trial of the experimental drug suggests major benefits for patients with diabetes and chronic kidney disease, an analysis of data conducted after the SONAR study was halted shows.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Nephrology News Source Type: news